01
Clinical
Clinical Trial on the Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastric Cancer
Jia Wei is leading a Phase I trial assessing the safety and preliminary efficacy of XH001 injection combined with neoantigen vaccine-induced tumor-specific T-cell injection in advanced gastric cancer. The study aims to determine if this combined cellular and vaccine approach can shrink tumors and prolong survival in adult patients.